$ELDN

$2.41 +$0.20 (9.05%) Close

$ELDN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 81.3M shares outstanding

Who owns ELDN?

By type of holder

Institutions 57.3% Insiders 0.3% Everyone else 42.4%

Concentration Top 10 holders own 36.2%

BVF Inc/il 7.7% · BlackRock, Inc. 6.3%

Institutional ownership

57.3%

+4.8 pts vs last qtr

Institutional holders

157

+36 vs last qtr

Net shares bought

+3.9M

by institutions in Q2 2026

New / sold out

49 / 13

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Goldman Sachs Group Inc +2.1M
Millennium Management LLC NEW +979.7K

Biggest sellers in Q2 2026

Jefferies Financial Group Inc. SOLD OUT −1.1M
Blue Owl Capital Holdings LP −853.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Eledon Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+452.2%

+53.29% a year

Each share's claim on the business

−81.9%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

Institutional shares by how long they've been held

5+ years50% 3–5 years2% 1–3 years21% Under 1 year27%

Quarterly turnover

17.1%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting ELDN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BI BVF Inc/il	6.3M	7.74%	Unchanged	≤2021	0.6%
Shares held by quarter Peak holding6.3M (Q3'24) Change over 8 quarters0 Share of the company7.740% BVF Inc/il's full portfolio →
B BlackRock, Inc.	5.1M	6.31%	+741.6K (+16.9%)	≤2021	0.0%
Shares held by quarter Peak holding5.1M (Q2'26) Change over 8 quarters+4.9M Share of the company6.310% BlackRock, Inc.'s full portfolio →

BVF Inc/il

6.3M

% of company

7.74%

Change vs last qtr

Unchanged

Held since

≤2021

BlackRock, Inc.

5.1M

% of company

6.31%

Change vs last qtr

+741.6K (+16.9%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Eledon Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ELDN on Form N-PORT; together they hold 14.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$9.78M	2.5M	3.06%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$8.03M	2.0M	2.51%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$9.78M

% of company

3.06%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$8.03M

% of company

2.51%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Eledon Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GD Gros David-Alexandre C Insider	168.7K	0.21%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.210% Gros David-Alexandre C's insider activity →
PS Perrin Steven Insider	81.2K	0.10%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.100% Perrin Steven's insider activity →

Gros David-Alexandre C

Insider

168.7K

% of company

0.21%

Change vs last qtr

—

Held since

—

Perrin Steven

Insider

81.2K

% of company

0.10%

Change vs last qtr

—

Held since

—

6 more holders behind a free account

See every insider and 5%+ holder of Eledon Pharmaceuticals Inc.

Comments